- Home
- KIDS vs EYPT Comparison
KIDS vs EYPT Comparison
Compare KIDS & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- EYPT
- Stock Information
- Founded
- KIDS 2007
- EYPT 1987
- Country
- KIDS United States
- EYPT United States
- Employees
- KIDS N/A
- EYPT N/A
- Industry
- KIDS Medical/Dental Instruments
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- KIDS Health Care
- EYPT Industrials
- Exchange
- KIDS Nasdaq
- EYPT Nasdaq
- Market Cap
- KIDS 601.5M
- EYPT 489.4M
- IPO Year
- KIDS 2017
- EYPT 2005
- Fundamental
- Price
- KIDS $24.26
- EYPT $7.69
- Analyst Decision
- KIDS Buy
- EYPT Strong Buy
- Analyst Count
- KIDS 6
- EYPT 8
- Target Price
- KIDS $37.67
- EYPT $25.71
- AVG Volume (30 Days)
- KIDS 317.8K
- EYPT 665.0K
- Earning Date
- KIDS 03-05-2025
- EYPT 03-06-2025
- Dividend Yield
- KIDS N/A
- EYPT N/A
- EPS Growth
- KIDS N/A
- EYPT N/A
- EPS
- KIDS N/A
- EYPT N/A
- Revenue
- KIDS $189,673,000.00
- EYPT $45,713,000.00
- Revenue This Year
- KIDS $39.26
- EYPT N/A
- Revenue Next Year
- KIDS $18.08
- EYPT N/A
- P/E Ratio
- KIDS N/A
- EYPT N/A
- Revenue Growth
- KIDS 33.47
- EYPT 7.50
- 52 Week Low
- KIDS $21.02
- EYPT $6.90
- 52 Week High
- KIDS $35.99
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- KIDS 45.67
- EYPT 41.66
- Support Level
- KIDS $23.55
- EYPT $7.58
- Resistance Level
- KIDS $25.45
- EYPT $8.16
- Average True Range (ATR)
- KIDS 1.26
- EYPT 0.55
- MACD
- KIDS -0.28
- EYPT -0.07
- Stochastic Oscillator
- KIDS 20.48
- EYPT 3.06
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.